All Sauce from Weekly Sauce:

A new pill specifically designed to prevent migraines appears to do the job, a new clinical trial finds. Atogepant cut patients’ migraine days in half over 12 weeks of treatment, without causing serious side effects, the researchers said. Experts said the drug, if approved by the U.S. Food and Drug Administration, would give migraine sufferers…  read on >  read on >

After concluding that a third dose of a coronavirus vaccine is needed to fight off waning immunity in the fully vaccinated, the Biden administration said Wednesday it will begin offering booster shots to all Americans starting Sept. 20. The plan, which only involves the Pfizer and Moderna vaccines at this point, calls for Americans to…  read on >  read on >

Texas Governor Greg Abbott has tested positive for COVID-19 but has not experienced any symptoms, his office announced Tuesday. Abbott, who is fully vaccinated, is being treated with Regeneron’s monoclonal antibodies in an effort to shorten the duration of the infection, his communications director Mark Miner said in a statement Tuesday afternoon, CBS News reported.…  read on >  read on >